首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma
Authors:Regina M. Myers MD  Brian T. Hill MD  PhD  Bronwen E. Shaw MD  PhD  Soyoung Kim PhD  Heather R. Millard MPH  Minoo Battiwalla MD  MS  Navneet S. Majhail MD  MS  David Buchbinder MD  Hillard M. Lazarus MD  Bipin N. Savani MD  Mary E. D. Flowers MD  Anita D'Souza MD  MS  Matthew J. Ehrhardt MD  MS  Amelia Langston MD  Jean A. Yared MD  Robert J. Hayashi MD  Andrew Daly MDCM  Richard F. Olsson MD  PhD  Yoshihiro Inamoto MD  PhD  Adriana K. Malone MD  Zachariah DeFilipp MD  Steven P. Margossian MD  PhD  Anne B. Warwick MD  MPH  Samantha Jaglowski MD  MPH  Amer Beitinjaneh MD  MPH  Henry Fung MD  Kimberly A. Kasow DO  David I. Marks MD  PhD  Jana Reynolds MD  Keith Stockerl‐Goldstein MD  Baldeep Wirk MD  William A. Wood MD  MPH  Mehdi Hamadani MD  Prakash Satwani MD
Affiliation:1. Divisions of Hematology and Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, Pennsylvania;2. Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio;3. Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin;4. Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, Wisconsin;5. Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland;6. Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio;7. Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, California;8. Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio;9. Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;10. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington;11. St Jude Children's Research Hospital, Memphis, Tennessee;12. Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia;13. Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland;14. Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri;15. Tom Baker Cancer Center, Calgary, Alberta, Canada;16. Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;17. Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden;18. Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan;19. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York;20. Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, Massachusetts;21. Department of Pediatric Oncology, Boston Children's Hospital and Dana‐Farber Cancer Institute, Boston, Massachusetts;22. Department of Pediatrics, Uniformed Services Industry of the Health Sciences, Bethesda, Maryland;23. Division of Hematology, Ohio State University Medical Center, Columbus, Ohio;24. University of Miami, Miami, Florida;25. Department of Medical Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania;26. Division of Hematology‐Oncology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina;27. Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom;28. Baylor University Medical Center, Dallas, Texas;29. Division of Oncology, Washington University School of Medicine, St. Louis, Missouri;30. Division of Bone Marrow Transplant, Seattle Cancer Care Alliance, Seattle, Washington;31. Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina;32. Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics, Columbia University Medical Center, New York, New York
Abstract:
Keywords:autologous hematopoietic cell transplant  diffuse large B‐cell lymphoma  Hodgkin lymphoma  late effects  nonrelapse mortality  survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号